{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:58:17Z","timestamp":1781236697622,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal De Campina Grande"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To assess factors associated with methotrexate-induced oral mucositis and its impact on the quality of life of pediatric patients with acute lymphoblastic leukemia, considering chemotherapy dose and mucositis severity within a clinical context where photobiomodulation is routinely used as part of the institutional care protocol. A cross-sectional study was conducted with 113 pediatric patients aged 5 to 18 years undergoing methotrexate-based chemotherapy between 2020 and 2024 in a university hospital in Northeastern Brazil. Data were collected using the Children\u2019s International Mucositis Evaluation Scale (ChIMES; self-report and proxy), the Child Oral Impacts on Daily Performances (C-OIDP), the WHO Oral Mucositis Grading Scale, photobiomodulation records, and chemotherapy regimen data. Descriptive statistics, Spearman correlation, and multiple linear regression analyses were performed (\u03b1\u2009=\u20090.05). Among the participants, 85% reported a high impact on quality of life. The mean age was 10.8 years (SD\u2009=\u20093.49), and most participants were boys. Higher mucositis severity, older age, higher methotrexate doses, and longer wound healing time were associated with worse quality of life. A strong positive correlation was observed between C-OIDP and ChIMES scores (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). In the regression analysis, mucositis severity (\u03b2\u2009=\u20090.304;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.021) and wound healing time (\u03b2\u2009=\u20090.492;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) remained significantly associated with higher impact scores. Methotrexate-induced oral mucositis was associated with a substantial negative impact on quality of life in pediatric patients with acute lymphoblastic leukemia. Greater mucositis severity and longer wound healing time were the main factors associated with worse outcomes. Although photobiomodulation was systematically applied as a preventive and therapeutic intervention, no causal inference regarding its independent effect can be established.\n                  <\/jats:p>","DOI":"10.1007\/s10103-026-04903-7","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:23:49Z","timestamp":1781234629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of oral mucositis treated by photobiomodulation protocol on the quality of life of pediatric oncology patients with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"41","author":[{"given":"William","family":"Alves de Melo J\u00fanior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Correia Basto da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Suely Barros Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00edssa","family":"C\u00e1ssia Gomes Aciole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Luiz Affonso Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Aparecida da Silva Pinhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"4903_CR1","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1038\/s41598-020-63528-0","volume":"10","author":"A Kakeje","year":"2020","unstructured":"Kakeje A, Alhalabi MM, Ghareeb A, Zahra B, Albuni Y, Hamid A et al (2020) Rates and trends of childhood acute lymphoblastic leukaemia: an epidemiology study. Sci Rep 10:6756. https:\/\/doi.org\/10.1038\/s41598-020-63528-0","journal-title":"Sci Rep"},{"key":"4903_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-019-01144-3","author":"M Sajith","year":"2019","unstructured":"Sajith M, Pawar A, Bafna V et al (2019) Serum methotrexate level and side effects of high-dose methotrexate infusion in pediatric patients with acute lymphoblastic leukemia. Indian J Hematol Blood Transfus. https:\/\/doi.org\/10.1007\/s12288-019-01144-3","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"1","key":"4903_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13046-020-01715-7","volume":"39","author":"C Pulito","year":"2020","unstructured":"Pulito C, Cristaudo A, Porta C, Zapperi S et al (2020) Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res 39(1):210. https:\/\/doi.org\/10.1186\/s13046-020-01715-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"4903_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.25122\/jml-2023-0060","volume":"16","author":"NI Helei","year":"2023","unstructured":"Helei NI, Helei VM, Zhulkevych IV (2023) Secondary lesions of the mucous membrane of the oral cavity as a side effect of complex anticancer treatment: a literature review. J Med Life 16(11):1585\u20131590. https:\/\/doi.org\/10.25122\/jml-2023-0060","journal-title":"J Med Life"},{"key":"4903_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06199-5","author":"M Curra","year":"2021","unstructured":"Curra M, Gabriel AF, Ferreira MBC et al (2021) Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy. Support Care Cancer. https:\/\/doi.org\/10.1007\/s00520-021-06199-5","journal-title":"Support Care Cancer"},{"issue":"12","key":"4903_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.oraloncology.2009.08.006","volume":"45","author":"ST Sonis","year":"2009","unstructured":"Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45(12):1015\u20131020","journal-title":"Oral Oncol"},{"key":"4903_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1718652","author":"A Villa","year":"2020","unstructured":"Villa A, Sonis ST (2020) An update on pharmacotherapies in active development for the management of cancer regimen-associated oral mucositis. Expert Opin Pharmacother. https:\/\/doi.org\/10.1080\/14656566.2020.1718652","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"4903_CR8","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/ijerph17041235","volume":"17","author":"LCL Damascena","year":"2020","unstructured":"Damascena LCL, Lucena NNN, Ribeiro ILA et al (2020) Severe oral mucositis in pediatric cancer patients: survival analysis and predictive factors. Int J Environ Res Public Health 17(4):1235. https:\/\/doi.org\/10.3390\/ijerph17041235","journal-title":"Int J Environ Res Public Health"},{"key":"4903_CR9","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/01635581.2017.1324995","volume":"69","author":"YH Chang","year":"2017","unstructured":"Chang YH, Yu MS, Wu KH (2017) Effectiveness of parenteral glutamine on methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia. Nutr Cancer 69:746\u2013751","journal-title":"Nutr Cancer"},{"issue":"4","key":"4903_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40368-024-00919-1","volume":"25","author":"TS de Mac\u00eado","year":"2024","unstructured":"de Mac\u00eado TS, de Melo MCF, Ferreira AKA, da Silva-Selva ELMS, Godoy GP, Caldas J\u00fanior AF (2024) Chemotherapy-induced oral mucositis: hierarchical analysis of recurrence factors. Eur Arch Paediatr Dent 25(4):589\u2013596. https:\/\/doi.org\/10.1007\/s40368-024-00919-1","journal-title":"Eur Arch Paediatr Dent"},{"issue":"4","key":"4903_CR11","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.21037\/tcr.2020.02.77","volume":"9","author":"AHM Al-Rudayni","year":"2020","unstructured":"Al-Rudayni AHM, Gopinath D, Maharajan MK, Menon RK (2020) Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review. Transl Cancer Res 9(4):3126\u20133134. https:\/\/doi.org\/10.21037\/tcr.2020.02.77","journal-title":"Transl Cancer Res"},{"issue":"3","key":"4903_CR12","doi-asserted-by":"publisher","first-page":"151160","DOI":"10.1016\/j.soncn.2021.151160","volume":"37","author":"N Otmani","year":"2021","unstructured":"Otmani N, Hattad S (2021) Clinical outcome in children with chemotherapy-induced mucositis. Semin Oncol Nurs 37(3):151160. https:\/\/doi.org\/10.1016\/j.soncn.2021.151160","journal-title":"Semin Oncol Nurs"},{"issue":"3","key":"4903_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/biom13030418","volume":"13","author":"D Hafner","year":"2023","unstructured":"Hafner D, Hrast P, Toma\u017eevi\u010d T, Jazbec J, Kav\u010di\u010d M (2023) Photobiomodulation for chemotherapy-induced oral mucositis in pediatric patients. Biomolecules 13(3):418. https:\/\/doi.org\/10.3390\/biom13030418","journal-title":"Biomolecules"},{"issue":"24","key":"4903_CR14","doi-asserted-by":"publisher","first-page":"12995","DOI":"10.3390\/ijerph182412995","volume":"18","author":"MP Alvarez-Azaustre","year":"2021","unstructured":"Alvarez-Azaustre MP, Greco R, Llena C (2021) Oral health-related quality of life in adolescents as measured with the Child-OIDP questionnaire: a systematic review. Int J Environ Res Public Health 18(24):12995. https:\/\/doi.org\/10.3390\/ijerph182412995","journal-title":"Int J Environ Res Public Health"},{"issue":"10","key":"4903_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00520-024-08849-w","volume":"32","author":"AMGA Laheij","year":"2024","unstructured":"Laheij AMGA, Dillen LM, Nur E, Raber-Durlacher JE (2024) Self-perceived oral health in hemato-oncological patients and the relation to quality of life. Support Care Cancer 32(10):643. https:\/\/doi.org\/10.1007\/s00520-024-08849-w","journal-title":"Support Care Cancer"},{"key":"4903_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1477-7525-6-68","volume":"6","author":"RA Castro","year":"2008","unstructured":"Castro RA, Cortes MI, Le\u00e3o AT et al (2008) Child-OIDP index in Brazil: cross-cultural adaptation and validation. Health Qual Life Outcomes 6:68. https:\/\/doi.org\/10.1186\/1477-7525-6-68","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"4903_CR17","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/bjc.2013.618","volume":"109","author":"S Jacobs","year":"2013","unstructured":"Jacobs S, Baggott C, Agarwal R et al (2013) Validation of the Children\u2019s International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT. Br J Cancer 109(10):2515\u20132522. https:\/\/doi.org\/10.1038\/bjc.2013.618","journal-title":"Br J Cancer"},{"issue":"2","key":"4903_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/ipd.12718","volume":"31","author":"JB Valer","year":"2021","unstructured":"Valer JB, Curra M, Gabriel AF et al (2021) Oral mucositis in childhood cancer patients receiving high-dose methotrexate: prevalence, relationship with other toxicities and methotrexate elimination. Int J Paediatr Dent 31(2):238\u2013246. https:\/\/doi.org\/10.1111\/ipd.12718","journal-title":"Int J Paediatr Dent"},{"issue":"11","key":"4903_CR19","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.1007\/s00520-021-06206-9","volume":"29","author":"DM Guimar\u00e3es","year":"2021","unstructured":"Guimar\u00e3es DM, Ota TMN, Silva DAC et al (2021) Low-level laser or LED photobiomodulation on oral mucositis in pediatric patients under high doses of methotrexate: prospective, randomized, controlled trial. Support Care Cancer 29(11):6441\u20136447. https:\/\/doi.org\/10.1007\/s00520-021-06206-9","journal-title":"Support Care Cancer"},{"key":"4903_CR20","doi-asserted-by":"publisher","DOI":"10.23804\/ejpd.2018.19.03.13","author":"JA Garrocho-Rangel","year":"2018","unstructured":"Garrocho-Rangel JA, Herrera-Moncada M, M\u00e1rquez-Preciado R et al (2018) Oral mucositis in paediatric acute lymphoblastic leukemia patients receiving methotrexate-based chemotherapy: case series. Eur J Paediatr Dent. https:\/\/doi.org\/10.23804\/ejpd.2018.19.03.13","journal-title":"Eur J Paediatr Dent"},{"key":"4903_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/sj.bdj.4811972","volume":"198","author":"GM Deeming","year":"2005","unstructured":"Deeming GM, Collingwood J, Pemberton MN (2005) Methotrexate and oral ulceration. Br Dent J 198:83\u201385. https:\/\/doi.org\/10.1038\/sj.bdj.4811972","journal-title":"Br Dent J"},{"issue":"1","key":"4903_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1590\/0103-6440201802881","volume":"31","author":"ILA Ribeiro","year":"2020","unstructured":"Ribeiro ILA, Melo ACR, Lim\u00e3o NP, Bonan PRF, Lima Neto EA, Valen\u00e7a AMG (2020) Oral mucositis in pediatric oncology patients: a nested case-control to a prospective cohort. Braz Dent J 31(1):78\u201388. https:\/\/doi.org\/10.1590\/0103-6440201802881","journal-title":"Braz Dent J"},{"issue":"1","key":"4903_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s40368-019-00454-4","volume":"21","author":"JJ Parra","year":"2020","unstructured":"Parra JJ, Alvarado MC, Monsalve P, Costa ALF, Montesinos GA, Parra PA (2020) Oral health in children with acute lymphoblastic leukaemia: before and after chemotherapy treatment. Eur Arch Paediatr Dent 21(1):129\u2013136. https:\/\/doi.org\/10.1007\/s40368-019-00454-4","journal-title":"Eur Arch Paediatr Dent"},{"issue":"5","key":"4903_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3390\/children9050631","volume":"9","author":"FA Chaudhary","year":"2022","unstructured":"Chaudhary FA, Iqbal A, Khalid MD et al (2022) Validation and reliability testing of the Child Oral Impacts on Daily Performances (C-OIDP): cross-cultural adaptation and psychometric properties in Pakistani school-going children. Child (Basel) 9(5):631. https:\/\/doi.org\/10.3390\/children9050631","journal-title":"Child (Basel)"},{"issue":"7","key":"4903_CR25","doi-asserted-by":"publisher","first-page":"e30309","DOI":"10.1002\/pbc.30309","volume":"70","author":"D Shah","year":"2023","unstructured":"Shah D, Gupta A, Meena JP et al (2023) Efficacy and safety of zinc in the prevention of oral mucositis in children receiving chemotherapy: a randomized, double-blind, placebo-controlled trial. Pediatr Blood Cancer 70(7):e30309. https:\/\/doi.org\/10.1002\/pbc.30309","journal-title":"Pediatr Blood Cancer"},{"key":"4903_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2021.05.013","volume":"154","author":"P Patel","year":"2021","unstructured":"Patel P, Robinson PD, Baggott C et al (2021) Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update. Eur J Cancer 154:92\u2013101. https:\/\/doi.org\/10.1016\/j.ejca.2021.05.013","journal-title":"Eur J Cancer"},{"issue":"4","key":"4903_CR27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/ecc.12344","volume":"25","author":"LM Bezinelli","year":"2016","unstructured":"Bezinelli LM, Eduardo FP, Neves VD et al (2016) Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study. Eur J Cancer Care (Engl) 25(4):668\u2013674. https:\/\/doi.org\/10.1111\/ecc.12344","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"7","key":"4903_CR28","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.5205\/1981-8963-v10i7a11296p2404-2411-2016","volume":"10","author":"WA Melo J\u00fanior","year":"2016","unstructured":"Melo J\u00fanior WA, Silva J\u00fanior EF, Calista AA et al (2016) Laser therapy in prevention and treatment of oral mucositis in pediatric oncology. J Nurs UFPE Online 10(7):2404\u20132411. https:\/\/doi.org\/10.5205\/1981-8963-v10i7a11296p2404-2411-2016","journal-title":"J Nurs UFPE Online"},{"issue":"5","key":"4903_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jcm7050090","volume":"7","author":"A Leite Cavalcanti","year":"2018","unstructured":"Leite Cavalcanti A, Jos\u00e9 de Mac\u00eado D, Suely Barros Dantas F et al (2018) Evaluation of oral mucositis occurrence in oncologic patients under antineoplastic therapy submitted to low-level laser therapy. J Clin Med 7(5):90. https:\/\/doi.org\/10.3390\/jcm7050090","journal-title":"J Clin Med"},{"issue":"3","key":"4903_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/photob.2018.4526","volume":"37","author":"SL Pinheiro","year":"2019","unstructured":"Pinheiro SL, Bonadiman AC, Borges Lemos ALDA et al (2019) Photobiomodulation therapy in cancer patients with mucositis: a clinical evaluation. Photobiomodul Photomed Laser Surg 37(3):142\u2013150. https:\/\/doi.org\/10.1089\/photob.2018.4526","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"4903_CR31","doi-asserted-by":"publisher","first-page":"103543","DOI":"10.1016\/j.pdpdt.2023.103543","volume":"42","author":"AFN Lessa","year":"2023","unstructured":"Lessa AFN, Celestino MA, Ferreira JM et al (2023) Antimicrobial photodynamic therapy for the treatment of oral mucositis: a comparative study. Photodiagnosis Photodyn Ther 42:103543. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103543","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"1","key":"4903_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3322\/caac.21704","volume":"72","author":"S Elad","year":"2022","unstructured":"Elad S, Yarom N, Zadik Y, Kuten-Shorrer M, Sonis ST (2022) The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies. CA Cancer J Clin 72(1):57\u201377. https:\/\/doi.org\/10.3322\/caac.21704","journal-title":"CA Cancer J Clin"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04903-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04903-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:23:54Z","timestamp":1781234634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04903-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4903"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04903-7","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee under CAAE number 40132420.6.0000.5182.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all research participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"114"}}